Impact of Enterococcus faecalis endocarditis treatment on risk of relapse - Archive ouverte HAL Access content directly
Journal Articles Clinical Infectious Diseases Year : 2022

Impact of Enterococcus faecalis endocarditis treatment on risk of relapse

(1) , (1) , (2) , (3) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (1) , (13, 14) , (15) , (15) , (2, 16) , (17, 1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Cyrielle Codde
  • Function : Author

Abstract

Abstract Background Enterococcus faecalis infective endocarditis (EFIE) are characterized by a higher frequency of relapses than other infective endocarditis. The role of the treatment on their occurrence remains poorly understood. The aim of this study was to investigate whether the antibiotic regimen could impact the risk of relapse in EFIE. Materials This was a multicenter retrospective study of patients diagnosed with definite EFIE between 2015 and 2019 in 14 French hospitals. The primary endpoint was the occurrence of relapses within the year following endocarditis diagnosis. As death was a competing risk for relapse, Fine & Gray models were used for studying risk factors and impact of treatment. Results Of the 279 patients included, 83 (29.7%) received the amoxicillin-gentamicin (A-G) combination, 114 (40.9%) amoxicillin-ceftriaxone (A-C), 63 (22.6%) A-G and A-C (A-G/A-C) sequentially, 9 (3.2%) amoxicillin (A), and 10 received other treatments. One-year-relapse rate was 9.3% (26 patients). Relapse occurred after a median delay of 107 days from EFIE diagnosis; 6 occurred after 6 months, and 6 were diagnosed by blood cultures in asymptomatic patients. In multivariate analysis, surgery during treatment was a protective factor against one-year relapse and death. The cumulative incidence of relapse one year after endocarditis was 46.2% for patients treated with amoxicillin, 13.4% with A-G, 14.7% with A-C, and 4.3% with A-G/A-C (P≥.05 in multivariate analysis). Conclusion Relapses after treatment of EFIE are frequent, frequently asymptomatic, and may occur more than 6 months after the initial episode.
Fichier principal
Vignette du fichier
ciac777.pdf (1.6 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03782705 , version 1 (21-09-2022)

Identifiers

Cite

Pierre Danneels, Jean François Hamel, Léa Picard, Schéhérazade Rezig, Pauline Martinet, et al.. Impact of Enterococcus faecalis endocarditis treatment on risk of relapse. Clinical Infectious Diseases, 2022, pp.ciac777. ⟨10.1093/cid/ciac777⟩. ⟨inserm-03782705⟩
21 View
11 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More